REGISTER NOW TO BECOME A MEMBER

You are viewing the 1st of the 2 courses UPMC Physician Resources permits you to view without registering. To have full access to our FREE courses on our website, please register or log in now.
Register

Dr. Shaw defines an AYA Oncology Patient and provides an overview of its prevalence and survival rates. He discusses a variety of groups and organizations involved with adolescent and young adult oncology, advocacy and awareness, and the results that they drive for research and clinical trials. Collaboration with medical oncologists and their successful results in patients is also covered.

Educational objectives:

Upon completion of this activity, participants should be able to:

  • Identify the reasons contributing to the different cancer survival rates between adolescent and young adult (AYA) patients and other age groups
  • Describe programmatic strategies being used to address these discrepancies and be able to implement them

Reading Resources:

  1. Shaw PH, Boyiadzis M, Tawbi H, Welsh A, Kemerer A, Davidson NE, Kim Ritchey A. Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions.  Cancer. 2011 Dec 27. [Epub ahead of print]
  2. Bleyer W, Barr R. Highlights and challenges. In: Bleyer A, O’Leary M, Barr R, et al, eds. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of age, Including SEER Incidence and Survival, 1975 to 2000. Bethesda, MD:National Cancer Institute, NIH Pub. No. 06-5767;2006. Also available at: www.seer.cancer.gov/publications/aya.
  3. NCCN Clinical Practical Guidelines in Oncology: Acute Lymphoblastic Leukemia Version 1.2012.  http://www.nccn.org/professionals/physician_gls/pdf/all.pdf
  4. Huguet F, Leguay T, Raffoux E, Thomas X, Beldjord K, Delabesse E, Chevallier P, Buzyn A, Delannoy A, Chalandon Y, Vernant JP, Lafage-Pochitaloff M, Chassevent A, Lhéritier V, Macintyre E, Béné MC, Ifrah N, Dombret H.  Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.  J Clin Oncol. 2009 Feb 20;27(6):911-8.
  5. Shaw PH, Ritchey AR. Different rates of clinical trial enrollment between adolescents and young adults aged 15 to 22 years old and children under 15 years old with cancer at a children’s hospital. J Pediatr Hematol Oncol. 2007;29:811–814.
  6. Yeager ND, Hoshaw-Woodard S, Ruymann FB, et al. Patterns of care among adolescents with malignancy in Ohio. J Pediatr Hematol Oncol. 2006;28:17–22.

Disclosures:

Dr. Shaw has no relevant relationships with any entities producing healthcare goods or services.

Accreditation Statement:

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.075) continuing education units (CEU) which are equivalent to 0.75 contact hours.

For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.edu and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.

Release Date: 9/11/2012 | Last Modified On: 10/15/2013 | Expires: 10/15/2014

This course has been expired.